Thomas Taapken

Discovers and develops therapeutics for neurological diseases

Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions.

Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies

Engages in research, development and commercialization of pharmaceutical products

Engages in the development and commercialization of in vitro diagnostic tests for cancer

DVC is a venture capital investment manager focused on European high-growth, early-stage companies with global expansion potential. The firm invests in sectors including life sciences, information technology, telecommunication, semiconductor and industrial technologies. In the field of life sciences, DVC invests specifically in the development of therapeutic products, diagnostics, medical devices and biotechnology platforms. Their technology investments target businesses whose activity pertains to 1) the management of information, applications and infrastructure, 2) communication applications and platforms as well as network infrastructure, and 3) technologies related to optics, automation, sensors, electronics, semiconductors and materials. DVC aims to leverage their access to Deutsche Bank's international network and lead their portfolio companies from technological leadership to international market success. Investment criteria include distinctive technology with adequate IP protection and addressing a clearly identified market, an experienced management team and leadership potential in high-growth markets internationally. The firm is generally the lead investor in German-speaking countries, and co-leads in other European countries and the US. They aim to keep their portfolio balanced across their target sectors and across development stages, with a majority of early-stage investments complemented with expansion-phase investments with short-term exit potential. DVC actively assists their portfolio companies with financial issues, key hires and marketing strategy without interfering in operational management.

Develops point of care device for the detection of malignant melanoma

Discovers and develops new small molecule drugs

Functions as a College/University